200 related articles for article (PubMed ID: 24458311)
1. A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.
Lubin M; Chen H; Elicker B; Jones KD; Collard HR; Lee JS
Chest; 2014 Jun; 145(6):1333-1338. PubMed ID: 24458311
[TBL] [Abstract][Full Text] [Related]
2. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS
Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413
[TBL] [Abstract][Full Text] [Related]
3. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
[TBL] [Abstract][Full Text] [Related]
4. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
[TBL] [Abstract][Full Text] [Related]
5. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
[TBL] [Abstract][Full Text] [Related]
6. Gender influences Health-Related Quality of Life in IPF.
Han MK; Swigris J; Liu L; Bartholmai B; Murray S; Giardino N; Thompson B; Frederick M; Li D; Schwarz M; Limper A; Flaherty K; Martinez FJ
Respir Med; 2010 May; 104(5):724-30. PubMed ID: 20036113
[TBL] [Abstract][Full Text] [Related]
7. Chronic hypersensitivity pneumonitis: identification of key prognostic determinants using automated CT analysis.
Jacob J; Bartholmai BJ; Egashira R; Brun AL; Rajagopalan S; Karwoski R; Kokosi M; Hansell DM; Wells AU
BMC Pulm Med; 2017 May; 17(1):81. PubMed ID: 28472939
[TBL] [Abstract][Full Text] [Related]
8. Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease.
Berry CE; Drummond MB; Han MK; Li D; Fuller C; Limper AH; Martinez FJ; Schwarz MI; Sciurba FC; Wise RA
Chest; 2012 Sep; 142(3):704-711. PubMed ID: 22576634
[TBL] [Abstract][Full Text] [Related]
9. Acute exacerbations of fibrotic interstitial lung diseases.
Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
[TBL] [Abstract][Full Text] [Related]
10. Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures.
Furusawa H; Cardwell JH; Okamoto T; Walts AD; Konigsberg IR; Kurche JS; Bang TJ; Schwarz MI; Brown KK; Kropski JA; Rojas M; Cool CD; Lee JS; Wolters PJ; Yang IV; Schwartz DA
Am J Respir Crit Care Med; 2020 Nov; 202(10):1430-1444. PubMed ID: 32602730
[No Abstract] [Full Text] [Related]
11. ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF.
Durheim MT; Hoffmann-Vold AM; Eagan TM; Hovden AO; Lund MB; Bjerke G; Birring SS; Jonassen TM; Johansen OE; Sjåheim T
BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32576559
[TBL] [Abstract][Full Text] [Related]
12. Impact of physical functional capacity on quality of life in patients with interstitial lung diseases.
Sikora M; Jastrzębski D; Pilzak K; Ziora D; Hall B; Żebrowska A
Respir Physiol Neurobiol; 2023 Jul; 313():104064. PubMed ID: 37076026
[TBL] [Abstract][Full Text] [Related]
13. Chronic hypersensitivity pneumonitis is associated with an increased risk of venous thromboembolism: a retrospective cohort study.
Sobiecka M; Szturmowicz M; Lewandowska K; Kowalik A; Łyżwa E; Zimna K; Barańska I; Jakubowska L; Kuś J; Langfort R; Tomkowski W
BMC Pulm Med; 2021 Dec; 21(1):416. PubMed ID: 34920701
[TBL] [Abstract][Full Text] [Related]
14. Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis.
Witt S; Krauss E; Barbero MAN; Müller V; Bonniaud P; Vancheri C; Wells AU; Vasakova M; Pesci A; Klepetko W; Seeger W; Crestani B; Leidl R; Holle R; Schwarzkopf L; Guenther A
Respir Res; 2019 Mar; 20(1):47. PubMed ID: 30823880
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015.
Pedraza-Serrano F; Jiménez-García R; López-de-Andrés A; Hernández-Barrera V; Sánchez-Muñoz G; Puente-Maestu L; de-Miguel-Díez J
Medicine (Baltimore); 2019 May; 98(21):e15779. PubMed ID: 31124970
[TBL] [Abstract][Full Text] [Related]
16. Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis.
Prior TS; Hilberg O; Shaker SB; Davidsen JR; Hoyer N; Birring SS; Bendstrup E
BMC Pulm Med; 2019 Dec; 19(1):255. PubMed ID: 31856786
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Renin and Soluble (Pro)renin Receptor in Patients with IPF. A Comparison with Hypersensitivity Pneumonitis.
Eduardo M; Ivette BR; Gabriela DP; Veronica MA; Victor R
Lung; 2019 Dec; 197(6):715-720. PubMed ID: 31616976
[TBL] [Abstract][Full Text] [Related]
18. ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases.
Hirata M; Hara Y; Fujii H; Murohashi K; Saigusa Y; Zhao S; Kobayashi M; Nagasawa R; Tagami Y; Izawa A; Otsu Y; Watanabe K; Horita N; Kobayashi N; Kaneko T
BMC Pulm Med; 2024 Jan; 24(1):16. PubMed ID: 38183005
[TBL] [Abstract][Full Text] [Related]
19. Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.
Alberti ML; Malet Ruiz JM; Fernández ME; Fassola L; Caro F; Roldán IB; Paulin F
Pulmonology; 2020; 26(1):3-9. PubMed ID: 31735689
[TBL] [Abstract][Full Text] [Related]
20. Predicting survival across chronic interstitial lung disease: the ILD-GAP model.
Ryerson CJ; Vittinghoff E; Ley B; Lee JS; Mooney JJ; Jones KD; Elicker BM; Wolters PJ; Koth LL; King TE; Collard HR
Chest; 2014 Apr; 145(4):723-728. PubMed ID: 24114524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
